APA

Naimi R. M., Hvistendahl M., Enevoldsen L. H., Madsen J. L., Fuglsang S., Poulsen S. S., Kissow H., Pedersen J., Nerup N., Ambrus R., Achiam M. P., Svendsen L. B., Holst J. J., Hartmann B., Hansen S. H., Dragsted L. O., Steensberg A., Mouritzen U., Hansen M. B. & Jeppesen P. B. (20200602). Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. : The lancet. Gastroenterology & hepatology.

Chicago

Naimi Rahim M, Hvistendahl Mark, Enevoldsen Lotte H, Madsen Jan L, Fuglsang Stefan, Poulsen Steen S, Kissow Hannelouise, Pedersen Jens, Nerup Nikolaj, Ambrus Rikard, Achiam Michael P, Svendsen Lars B, Holst Jens J, Hartmann Bolette, Hansen Svend H, Dragsted Lars O, Steensberg Adam, Mouritzen Ulrik, Hansen Mark B and Jeppesen Palle B. 20200602. Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. : The lancet. Gastroenterology & hepatology.

Harvard

Naimi R. M., Hvistendahl M., Enevoldsen L. H., Madsen J. L., Fuglsang S., Poulsen S. S., Kissow H., Pedersen J., Nerup N., Ambrus R., Achiam M. P., Svendsen L. B., Holst J. J., Hartmann B., Hansen S. H., Dragsted L. O., Steensberg A., Mouritzen U., Hansen M. B. and Jeppesen P. B. (20200602). Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. : The lancet. Gastroenterology & hepatology.

MLA

Naimi Rahim M, Hvistendahl Mark, Enevoldsen Lotte H, Madsen Jan L, Fuglsang Stefan, Poulsen Steen S, Kissow Hannelouise, Pedersen Jens, Nerup Nikolaj, Ambrus Rikard, Achiam Michael P, Svendsen Lars B, Holst Jens J, Hartmann Bolette, Hansen Svend H, Dragsted Lars O, Steensberg Adam, Mouritzen Ulrik, Hansen Mark B and Jeppesen Palle B. Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. : The lancet. Gastroenterology & hepatology. 20200602.